Discover
ABOS
Acumen Pharmaceuticals, Inc.
2.69
2 x 1.92
1 x 3.41
bid
ask
+
0.10
3.86%
11:24 AM
timesize
| Ytd | 27.49% | |
| 1y | 138.05% |
2.62
day range
2.72
1.13
52 week range
3.60
| Open | 2.62 | Prev Close | 2.59 | Low | 2.62 | High | 2.72 | Mkt Cap | 194.29M |
| Vol | 146.47K | Avg Vol | 460.29K | EPS | -1.85 | P/E | N/A | Forward P/E | -1.17 |
| Beta | 0.04 | Short Ratio | 6.61 | Inst. Own | 78.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 2.43 | 200-d Avg | 2.27 | 1yr Est | 10.80 |
| Income Statement | |||
| Operating Expenses | 21.15M | ||
| Research and Development Expense | 16.48M | ||
| Selling, General and Administrative Expense | 4.67M | ||
| Operating Income | -21.15M | ||
| Interest Expense | 1.07M | ||
| Net Income | -20.74M | ||
| Net Income Common Stock | -20.74M | ||
| Net Income Common Stock (USD) | -20.74M | ||
| Consolidated Income | -20.74M | ||
| Earnings per Basic Share | -0.33 | ||
| Earnings per Basic Share (USD) | -0.33 | ||
| Earnings per Diluted Share | -0.33 | ||
| Earning Before Interest & Taxes (EBIT) | -19.67M | ||
| Earning Before Interest & Taxes (USD) | -19.67M | ||
| Weighted Average Shares | 63.22M | ||
| Weighted Average Shares Diluted | 63.22M | ||
| Balance Sheet | |||
| Cash and Equivalents | 52.03M | ||
| Cash and Equivalents (USD) | 52.03M | ||
| Investments | 76.60M | ||
| Investments Current | 76.60M | ||
| Current Assets | 133.09M | ||
| Total Assets | 133.63M | ||
| Debt Current | 14.12M | ||
| Total Debt | 31.05M | ||
| Current Liabilities | 29.23M | ||
| Debt Non-Current | 16.92M | ||
| Total Liabilities | 46.15M | ||
| Accumulated Retained Earnings (Deficit) | -467.20M | ||
| Accumulated Other Comprehensive Income | 21.00K | ||
| Shareholders Equity | 87.48M | ||
| Shareholders Equity (USD) | 87.48M | ||
| Assets Non-Current | 535.00K | ||
| Total Debt (USD) | 31.05M | ||
| Liabilities Non-Current | 16.92M | ||
| Trade and Non-Trade Payables | 1.66M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 46.00K | ||
| Net Cash Flow from Financing | 35.74M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.19M | ||
| Issuance (Purchase) of Equity Shares | 35.74M | ||
| Net Cash Flow from Investing | -13.81M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -13.81M | ||
| Net Cash Flow from Operations | -24.13M | ||
| Share Based Compensation | 2.40M | ||